Iovance Biotherapeutics Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
© -
Hi, there. My name is Evan Seigerman. I am the senior large-cap biotechnology analyst here at Crédit Suisse. And it is my pleasure to introduce Iovance Therapeutics. And from Iovance is the CFO, Tim Morris.
Thank you very much. Thank you, Evan, for that kind introduction. Thank you again to Crédit Suisse. It's always a pleasure to come down to Scottsdale and present to the audience and those out here on the webcast. Again, I'm Tim Morris, Chief Financial Officer.
I will make forward-looking statements during the course of this presentation. So please refer to my SEC documents for information and risk that will impact your investment decision.
A little bit of a time line here. It is kind of amazing how much the company has been able to accomplish in at about 3 years. The technology was
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
